Dr. Sonja Merkas, PhDFounder and CEO at LivinoveaSpeaker
Profile
Sonja is the founder of Livinovea, a Switzerland-based consultancy and service provider supporting biotech, pharma, startups, and CDMOs across the drug development and manufacturing value chain. Livinovea integrates science and technology with market positioning and operational strategy — translating complexity into execution and measurable results. Clients engage us for:
1. Operational efficiency, cost reduction, operational excellence
2. Market positioning, business development, and growth strategy
3. CMC, technical transfer, due diligence, and hands-on troubleshooting across RNA, oligonucleotides, small molecules, and peptides
Outside Perspective. Inside Execution. Measurable Results.
Sonja brings over 25 years of experience in the life science industry and consulting, with a focus on oligonucleotide and small molecule therapeutics since 2003 — including 10 years at Novartis leading the oligonucleotide development portfolio. She holds a PhD in Chemistry and a Lean Six Sigma Black Belt.
Agenda Sessions
CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
, 09:00View SessionChairwoman's Remarks: Innovations in Oligonucleotide CMC
, 08:00View Session